Corcept Therapeutics Incorporated logo
Corcept Therapeutics Incorporated CORT
$ 38.66 -4.47%

Annual report 2025
added 02-24-2026

report update icon

Corcept Therapeutics Incorporated Operating Cash Flow 2011-2026 | CORT

Annual Operating Cash Flow Corcept Therapeutics Incorporated

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
142 M 198 M 127 M 120 M 168 M 152 M 136 M 116 M 60.9 M 18.4 M - - -37.1 M -36 M -27.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
198 M -37.1 M 87.5 M

Quarterly Operating Cash Flow Corcept Therapeutics Incorporated

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 5.13 M - - 23.8 M - - 26 M - 86.9 M - 35.2 M - 118 M - 25.4 M - 117 M 86.5 M 33.3 M - 87.7 M 49.2 M 23.7 M - 94.1 M 49.6 M 34.4 M - 36.1 M 25.1 M - - - - - - - - - - - - - - - - -11.6 M - -27.3 M -18 M -10.2 M - -21.1 M -14.5 M -7.3 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
118 M -27.3 M 33.9 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer Operating Cash Flow Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
-481 M - 2.43 % $ 254 M germanyGermany
ARCA biopharma ARCA biopharma
ABIO
-57.8 M - 1052.0 % $ 415 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
-8.58 M - 5.93 % $ 314 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
-230 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
-63.7 M - 0.23 % $ 488 M usaUSA
I-Mab I-Mab
IMAB
-1.3 B - - $ 866 M chinaChina
Genfit SA Genfit SA
GNFT
99.9 M - 2.54 % $ 160 B franceFrance
Albireo Pharma Albireo Pharma
ALBO
-108 M - -0.23 % $ 916 M usaUSA
Biophytis SA Biophytis SA
BPTS
-23.8 M - -13.47 % $ 169 M franceFrance
REGENXBIO REGENXBIO
RGNX
-124 M $ 8.39 -0.83 % $ 433 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
-22.3 M - 10.36 % $ 9.8 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-6.01 M - -18.52 % $ 27.3 M britainBritain
Cabaletta Bio Cabaletta Bio
CABA
-131 M $ 2.79 0.18 % $ 280 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
-65.7 M - - $ 26.5 M usaUSA
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
75.7 M $ 26.27 -0.08 % $ 473 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
-18 M - -10.17 % $ 12.2 K usaUSA
Aptinyx Aptinyx
APTX
-59.7 M - -39.0 % $ 4.57 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
-14 M - -24.86 % $ 820 K usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
-13.1 M $ 2.88 4.35 % $ 599 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-14.9 M - 4.01 % $ 150 M canadaCanada
Equillium Equillium
EQ
-22.7 M $ 2.08 0.97 % $ 119 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
-92.5 M - - $ 86.2 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-30.3 M - 2.71 % $ 14 M usaUSA
Advaxis Advaxis
ADXS
-29.5 M - -9.65 % $ 45.9 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
-34.5 M - - $ 7.46 M israelIsrael
Avenue Therapeutics Avenue Therapeutics
ATXI
-9.03 M - -52.27 % $ 4.45 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
-206 M $ 1.33 -0.38 % $ 339 M britainBritain
Atreca Atreca
BCEL
-80.7 M - -11.76 % $ 5.79 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
1.13 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Relay Therapeutics Relay Therapeutics
RLAY
-249 M $ 9.87 2.81 % $ 1.41 B usaUSA
bluebird bio bluebird bio
BLUE
-235 M - - $ 546 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
41 M - -4.8 % $ 255 M usaUSA
Cara Therapeutics Cara Therapeutics
CARA
-92.1 M - -3.03 % $ 260 M usaUSA
ChemoCentryx ChemoCentryx
CCXI
-75.6 M - - $ 3.74 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
-169 M - - $ 1.01 B usaUSA
Avid Bioservices Avid Bioservices
CDMO
11 M - - $ 789 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-733 M - - $ 867 M germanyGermany
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-17.8 M - -74.18 % $ 955 K usaUSA
Avidity Biosciences Avidity Biosciences
RNA
-650 M $ 13.12 0.23 % $ 1.81 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
-345 M $ 48.11 2.17 % $ 4.33 B schweizSchweiz
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
-39.6 M $ 4.54 0.11 % $ 870 M canadaCanada
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
-4.29 M $ 2.95 -1.34 % $ 5.65 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
-15.1 M - 1.93 % $ 17.4 M usaUSA
Royalty Pharma plc Royalty Pharma plc
RPRX
2.49 B $ 47.33 0.64 % $ 20.3 B usaUSA
Kazia Therapeutics Limited Kazia Therapeutics Limited
KZIA
-22.8 M $ 6.96 -4.66 % $ 922 M australiaAustralia
Allakos Allakos
ALLK
-116 M - - $ 28.6 M usaUSA
Brickell Biotech Brickell Biotech
BBI
-4.34 M - -5.38 % $ 6.06 M usaUSA